Notice of Knight Therapeutics' Fourth Quarter and Year End 2023 Results Conference Call Pharmaceutical Investing
Jamieson Wellness Inc. Reports Strong Fourth Quarter and Full Year 2023 Results Pharmaceutical Investing
Jamieson Wellness Inc. Announces Date of Fourth Quarter and Full Year 2023 Financial Results and Conference Call Pharmaceutical Investing
Salix Pharmaceuticals Announces a Phase 2 Investigator-Initiated Study of RELISTOR in Patients with Resectable Head and Neck Squamous Cell Carcinoma Pharmaceutical Investing
New Survey Finds More Than Half of Past U.S. Colonoscopy Patients Wish They Had Known More Information About Colonoscopies Including Prep Medication Options and How To Prepare for the Procedure Pharmaceutical Investing
Knight Therapeutics Announces Regulatory Submission of Fostamatinib in Brazil Pharmaceutical Investing
